申请人:ELI LILLY AND COMPANY
公开号:EP0122018A2
公开(公告)日:1984-10-17
Compounds of the formula
or a pharmaceutically acceptable acid addition salt thereof, in which
R is hydrogen, methyl, ethyl, cyclopropylmethyl, or allyl;
A is a residue of a D-amino acid which is Ala, Abu, Nva, Val, Nle, Leu, Ile, Gly(Al), Gly(Cp), Met, Cys (Me), Met(O), Cys(Me)(O), Ser, Ser(Me), Thr, or Hse;
R1 is hydrogen, C1-C3 primary alkyl, cyclopropylmethyl, allyl, ethylthiomethyl, 2-fluoroethyl, or propargyl;
X is hydrogen, fluoro, bromo, iodo, chloro, hydroxy, C1-C3 alkyl, trifluoromethyl, or C1-C2 alkoxy; and
m is 0 or 1; which are useful as analgesic agents are described herein.
式化合物
或其药学上可接受的酸加成盐,其中
R 是氢、甲基、乙基、环丙基甲基或烯丙基;
A 是 D-氨基酸的残基,它是 Ala、Abu、Nva、Val、Nle、Leu、Ile、Gly(Al)、Gly(Cp)、Met、Cys (Me)、Met(O)、Cys(Me)(O)、Ser、Ser(Me)、Thr 或 Hse;
R1 是氢、C1-C3 伯烷基、环丙基甲基、烯丙基、乙硫基甲基、2-氟乙基或丙炔基;
X 是氢、氟、溴、碘、氯、羟基、C1-C3 烷基、三氟甲基或 C1-C2 烷氧基;以及
m 是 0 或 1;可用作镇痛剂,详见本文所述。